Jeffrey M. Rothschild

Papers

Total Citations

H-Index

About

Jeffrey M. Rothschild is a leading researcher in medication safety and healthcare quality, with a particular focus on the safe preparation and administration of high-risk drugs, including antineoplastic agents. His work has been instrumental in advancing the understanding of how technology can reduce human error in pharmacy practice. In his highly cited 2012 study, "Impact of Robotic Antineoplastic Preparation on Safety, Workflow, and Costs," Rothschild demonstrated that robotic compounding not only enhances safety by minimizing exposure and preparation errors but also improves workflow efficiency and reduces long-term operational costs. This landmark paper, with over 70 citations, has influenced pharmacy protocols and the adoption of automation in hospitals worldwide. Beyond this, Rothschild has made significant contributions to the broader field of patient safety, including landmark studies on adverse drug events and the role of clinical decision support systems. His work has been published in top-tier journals such as JAMA and the New England Journal of Medicine, and his findings have shaped national safety guidelines. For students and researchers, Rothschild’s career exemplifies how rigorous, real-world evaluation of technology can directly improve patient outcomes and reshape clinical practice.